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Abstract
Purpose Intraoperative neuromonitoring (IONM) can serve
as a tool to increase skills in recurrent laryngeal nerve
(RLN) identification and complete removal of thyroid tissue.
The aim of this study was to validate this hypothesis.
Methods This prospective study involved 632 patients (1161
RLNs at risk) who underwent thyroid surgery in 2011–2014.
Although IONM was not used until 2012, this prospective
study started on 1 January 2011. The three participating sur-
geons knew about the study before that date and that the rate
of RLN identification would be carefully measured in total
and near-total surgery. Solely, visual identification of the
RLN was used throughout 2011. IONM was introduced as a
training tool in 2012–2014 for the first 3 months of each year.
In the remaining months, thyroid operations were performed
without IONM. Outcomes of non-monitored thyroid opera-
tions were compared before (01-12/2011) vs. after (04-12/
2012–2014) 3 months of exposure to IONM yearly (01-03/
2012–2014). The rate of RLN identification was assessed in
total and near-total thyroidectomies and in totally resected
lobes in Dunhill’s operation. The prevalence of RLN injury
and the utilization of total thyroidectomy were evaluated.
Results In 2011, the rate of successful RLN visual identifica-
tion in total and near-total thyroidectomies and in totally
resected lobes in Dunhill’s operation was 45.71 %. After the
introduction of IONM in 2012–2014, in the procedures per-
formed without IONM, the rate was 86.66, 90.81, and 91.3 %.
The prevalence of RLN injury in 2011 was 6.8 %, while in the
years following the introduction of IONM, it was 3.61, 2.65,
and 1.45 %. Utilization of total thyroidectomy increased from
47.9 % in 2011 to 100 % in 2014.
Conclusions Experience with IONM led to an increase in
RLN identification (p<0.0001), a decrease of RLN injury
(p<0.05), and an increase in the safe utilization of total thy-
roidectomy (p<0.0001) in non-monitored thyroid operations.
IONM is a valuable tool for surgical training.
Keywords Intraoperative neuromonitoring . Thyroid
surgery . Recurrent laryngeal nerve . Surgical skill
Introduction
Recurrent laryngeal nerve (RLN) paresis is a serious compli-
cation of thyroid surgery, which can significantly deteriorate
the quality of life [1–4]. Intraoperative RLN identification
during thyroid surgery reduces the risk of accidental
injury and should be routinely performed during every
operation [4–7].
Currently, identification of the RLN can be facilitated with
intraoperative neuromonitoring (IONM), which is more and
more widely accepted as a standardizedmethod and utilized at
centers for thyroid surgery [7–10]. Neuromonitoring is a tool
that not only helps to visually identify the RLN but also pre-
dicts postoperative nerve function, which is a huge advantage
over visualization alone; this technique could help prevent
bilateral palsy [5]. Recently, there have been numerous
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publications assessing the value of IONM in thyroid surgery,
comparing the effect of these procedures with and without the
use of IONM [5, 11]. Considerably, fewer publications have
evaluated the educational value of neuromonitoring as a tool
in increasing surgeons’ insight into the operating field and
skill at identifying the RLN [7, 29]. Moreover, it is worth
considering whether the experience of working with IONM,
even short term, can affect the quality of thyroid operations
performed later—even those carried out without
neuromonitoring.
The aim of this study was to validate the hypothesis that
IONM can serve as a tool for increasing skills in RLN identi-
fication and safe, complete removal of thyroid tissue.
Material and methods
A total of 632 consecutive thyroidectomy patients treated at
the Department of General, Gastroenterological and
Endocrine Surgery of Wroclaw Medical University in
Wroclaw, Poland, between January 2011 and December
2014 were found to be eligible for this prospective study.
Although IONM was not used until 2012, this prospective
study started on 1 January 2011. The three participating sur-
geons knew about the study before that date and that the rate
of RLN identification would be carefully measured in total
and near-total surgery. Solely, visual identification of the
RLN was used in 2011. IONM was used as a training tool
for the first 3 months of 2012, 2013, and 2014. In the remain-
ing months of each year, thyroid operations were performed
without IONM (Table 1). The outcomes of non-monitored
thyroid operations were compared in two time periods: before
(01-12/2011) vs. after (04-12/2012–2014) 3 months of expo-
sure to IONM yearly (01-03/2012–2014). The primary end-
point was RLN identification, while the secondary endpoints
were the prevalence of RLN injury and the utilization of total
thyroidectomy. The study was approved by the Bioethics
Committee of Wroclaw Medical University.
All the patients enrolled in the study were comprehensively
diagnosed preoperatively and prepared for surgery by the
Department or by the outpatient Endocrinology Clinic, and
all of them were euthyroid. A greatly enlarged thyroid gland
in the course of a goiter, compression symptoms and suspicion
or diagnosis of a malignant thyroid tumor was the indications
for surgical treatment of these patients. All the patients’ thy-
roid gland function was reassessed upon admission to the
hospital, determining TSH and FT4 levels; routine chest and
neck X-rays were done to assess displacement, narrowing of
the trachea, and the presence of a retrosternal goiter. Other
tests in the preoperative period were typical of the standard
preparation of patients for any operating procedure. Before
each operation, the patient underwent ENT examination of
the vocal cords (indirect examination or videolaryngoscopy).
All the thyroid operations were performed by the same
three surgeons (mean age 41 years old) with similar experi-
ence in thyroid surgery, performing about 60 thyroid opera-
tions a year. None of the surgeons participating in the study
had much experience in RLN identification.
Before the initial use of the new technique, the surgical
team was trained on a 2-day practical introductory course in
neuromonitoring at the Department of Endocrine Surgery of
Jagiellonian University Medical College in Krakow, Poland.
The level of RLN identification without the use of IONM in
2011–2014 was assessed in total and near-total thyroidecto-
mies and in totally resected lobes in Dunhill’s operation. RLN
identification in subtotal thyroidectomies was excluded from
these assessments, because in most of these cases, the RLN
was not routinely identified.
A typical cervicotomy was performed in primary thyroid’s
operations; in secondary operations, a standard cervicotomy
with excision of the existing scar was performed. Usually, an
anterior approach between the strap muscles was used for
primary thyroidectomy. In reoperations, the lateral approach
(between the strap muscles and the sternocleidomastoid mus-
cle) was routinely used. In operations without IONM, the first
step was visual identification of the RLN low in the neck
(below the crossing with the inferior thyroid artery, we used
the inferior thyroid artery as a landmark in visual identifica-
tion). Once the nerve was visually identified, it was carefully
dissected along its course towards the larynx. In operations
with IONM, the visual identification of the RLN was facilitat-
ed via the IONM system, with the nerve mapping technique.
Once the nerve was visually identified, repeated stimulations
with the monopolar probe of the IONM system served to trace
the nerve path in the operative field and test its functional
integrity during dissection. In each patient, the RLN was ex-
posed and the branches of the superior and inferior thyroid
arteries were divided close to the thyroid capsule (peripheral
ligation).
RLN monitoring was carried out according to the recom-
mendations of the International Neural Monitoring Study
Group [5] employing a NIM-3.0 nerve monitor (Medtronic,
Jacksonville, USA) and an intermittent IONM technique. A
monopolar stimulating probe was used for nerve stimulation
with a current amplitude of 1 mA (range 0.5–1.5 mA) and 3-
Hz impulses of 200 ms each for 1–2 s. Both the demographic
data and the surgical documentation of IONM use were col-
lected in a computerized medical database.
The postoperative follow-up was closely monitored in
all the patients. Functional assessment of the larynx was
performed on the first postoperative day by an ENT spe-
cialist using indirect laryngoscopy. The mobility of the
vocal cords in patients with postoperative dysfunction
was evaluated by videolaryngoscopy performed up to
6 months postoperatively. Cases in which the function
of the vocal cords was recovered within 6 months were
710 Langenbecks Arch Surg (2017) 402:709–717
T
ab
le
1
D
em
og
ra
ph
ic
da
ta
,i
nd
ic
at
io
ns
fo
r
su
rg
er
y,
an
d
se
le
ct
ed
de
ta
ils
of
th
e
pr
oc
ed
ur
es
V
is
ua
lR
L
N
id
en
tif
ic
at
io
n
(2
01
1,
an
d
04
-1
2/
20
12
-2
01
4)
R
L
N
id
en
tif
ic
at
io
n
w
ith
IO
N
M
(0
1-
03
/2
01
2–
20
14
)
p
va
lu
e
V
is
ua
lR
L
N
id
en
tif
ic
at
io
n
20
11
V
is
ua
lR
L
N
id
en
tif
ic
at
io
n
(0
1-
03
/2
01
2)
V
is
ua
lR
L
N
id
en
tif
ic
at
io
n
(0
1-
03
/2
01
3)
V
is
ua
lR
L
N
id
en
tif
ic
at
io
n
(0
1-
03
/2
01
4)
p
va
lu
e
N
o.
of
pa
tie
nt
s
39
6
23
6
N
C
11
9
93
10
8
76
N
C
R
L
N
s
at
ri
sk
72
7
43
4
N
C
23
5
16
6
18
8
13
8
N
C
M
ea
n
ag
e
±
SD
,y
ea
rs
53
.8
8
±
14
.4
3
53
.9
9
±
13
.3
6
0.
92
5a
55
.3
6
±
14
.0
0
55
.2
4
±
14
.0
9
51
.5
8
±
14
.1
8
53
.1
6
±
15
.6
5
0.
01
2b
Se
x
ra
tio
(F
:M
)
4.
3:
1
4.
6:
1
0.
75
2c
3.
8:
1
5.
6:
1
5:
1
3.
2:
1
0.
43
6d
N
od
ul
ar
go
ite
r,
no
.(
%
)
25
7
(6
4.
9
%
)
16
6
(7
0.
34
%
)
0.
16
3c
83
(6
9.
75
%
)
60
(6
4.
52
%
)
66
(6
1.
11
%
)
48
(6
3.
16
%
)
0.
32
0d
T
hy
ro
id
ca
nc
er
,n
o.
(%
)
27
(6
.8
2
%
)
35
(1
4.
83
%
)
0.
00
1c
7
(5
.8
8
%
)
4
(4
.3
0
%
)
9
(8
.3
4
%
)
7
(9
.2
1
%
)
G
ra
ve
’s
di
se
as
e,
no
.(
%
)
11
(2
.7
7
%
)
9
(3
.8
1
%
)
0.
48
8c
1
(0
.8
4
%
)
3
(3
.2
3
%
)
2
(1
.8
5
%
)
5
(6
.5
8
%
)
To
xi
c
no
du
la
r
go
ite
r,
no
.(
%
)
10
1
(2
5.
51
%
)
26
(1
1.
02
%
)
<
0.
00
1c
28
(2
3.
53
%
)
26
(2
7.
95
%
)
31
(2
8.
7
%
)
16
(2
1.
05
%
)
Pr
im
ar
y
su
rg
er
y,
no
.(
%
)
37
2
(9
3.
94
%
)
19
9
(8
4.
32
%
)
0.
00
1c
10
8
(9
0.
76
%
)
86
(9
2.
47
%
)
10
4
(9
6.
3
%
)
74
(9
7.
37
%
)
0.
16
5d
Se
co
nd
ar
y
su
rg
er
y,
no
.(
%
)
24
(6
.0
6
%
)
37
(1
5.
68
%
)
11
(9
.2
4
%
)
7
(7
.5
3
%
)
4
(3
.7
%
)
2
(2
.6
3
%
)
G
oi
te
r’
s
vo
lu
m
e,
m
ea
n
±
SD
,m
l
38
.5
6
±
29
.1
3
41
.2
5
±
34
.7
9
0.
46
6e
43
.8
7
±
35
.8
4
42
.5
7
±
35
.2
4
38
.4
±
30
.7
4
38
.8
±
26
.8
7
0.
17
1b
R
et
ro
st
er
na
lg
oi
te
r,
no
.(
%
)
79
(1
9.
94
%
)
52
(2
2.
03
%
)
0.
61
2c
23
(1
9.
33
%
)
18
(1
9.
35
%
)
22
(2
0.
37
%
)
16
(2
1.
05
%
)
0.
98
9d
C
om
pr
es
si
o
tr
ac
he
ae
,n
o.
(%
)
17
7
(8
0.
06
%
)
11
2
(4
7.
45
%
)
0.
51
0c
52
(4
3.
7
%
)
47
(5
0.
54
%
)
37
(3
4.
26
%
)
40
(5
2.
63
%
)
0.
04
5d
O
pe
ra
tin
g
tim
e,
m
ea
n
±
SD
,m
in
10
8.
5
(±
30
.4
7)
11
1.
7
(±
31
.3
7)
0.
59
6c
96
.3
(±
25
.4
4)
12
1.
3
(±
20
.6
)
10
7.
8
(±
34
.0
8)
93
.8
2
(±
28
.5
6)
<
0.
00
1f
p
va
lu
e
<
0.
05
w
as
co
ns
id
er
ed
st
at
is
tic
al
ly
si
gn
if
ic
an
t
IO
N
M
in
tr
ao
pe
ra
tiv
e
ne
ur
om
on
ito
ri
ng
,R
LN
re
cu
rr
en
tl
ar
yn
ge
al
ne
rv
e,
N
C
no
tc
al
cu
la
te
d
a
tt
es
t
b
A
N
O
V
A
te
st
c
Fi
sh
er
’s
ex
ac
tt
es
t
d
C
hi
-s
qu
ar
e
te
st
e
M
an
n-
W
hi
tn
ey
te
st
f
K
ru
sk
al
l-
W
al
is
te
st
Langenbecks Arch Surg (2017) 402:709–717 711
considered transient paresis, while an absence of vocal
cord mobility 6 months after the operation was consid-
ered permanent palsy.
Prism 5.0 statistical software (GraphPad, La Jolla, CA, US)
was utilized to analyze the data. Relationships between clini-
copathological parameters were analyzed by Fisher’s exact
test and the χ2 test. To compare the parametrical data, the
unpaired Student’s t test was used, while the Mann-Whitney
U test was used to compare groups of data which did not met
the assumptions of the parametric test. To compare more than
two groups, the Kruskal-Wallis test with post hoc analysis
using Dunn’s Multiple Comparison was utilized. In all the
analyses, the results were considered statistically significant
when p<0.05.
Results
Primary endpoint analysis: RLN identification in total
or near-total resection of thyroid lobes
Among 236 patients undergoing procedures with IONM (434
RLNs at risk), the RLN was positively identified in 94.93 %.
In 2012–2014, after three 3-month periods of exposi-
tion to neuromonitoring, there was an increase in the
surgeons’ ability to visually identify the RLN in total
resection of thyroid lobes without IONM (p< 0.0001).
The largest increase in RLN identification skills was ob-
served after the first 3 months of working with IONM in
2012 (101 thyroid operations; p< 0.0001). Increases in
RLN-identifying skills were also observed after the sec-
ond (n= 70) and third (n= 65) periods of IONM utiliza-
tion, but the values were not at the level of statistical
significance (p = 0.2929 and p = 1.0000, respectively).
The 3-year increase achieved statistical significance
(p< 0.0001) in the surgeons’ ability to visually identify
the RLN was observed in primary thyroid operations,
while among reoperations, the increase was not at the
level of statistical significance (p= 0.4268) (Table 2).
In patients with non-malignant thyroid disorders that
were operated radically, the visual RLN identification
rate in 2011, before the introduction of IONM, was
49.21 %; after the experience of working with IONM,
the rate of visual RLN identification in this group of
patients was 89.21 % in 2012, 97.53 % in 2013, and
91.94 % in 2014. This increase was statistically signifi-
cant (p< 0.0001). A lower percentage of correct visual
RLN identification was observed in patients with thyroid
cancer: 14.29 % in 2011, 66.67 % in 2012, 62.5 % in
2013, and 85.71 % in 2014; however, even in this group
of patients, the increase was statistically significant over
the period 2011–2014 (p= 0.001).
Secondary endpoints: the rate of RLN injury
and utilization of total thyroidectomy
In 2011–2014, the total rate of RLN palsy in the immediate
postoperative period of procedures without IONM fell to a
statistically significant degree after three 3-month exposures
to neuromonitoring (p=0.043). After each subsequent expo-
sure to IONM, the incidence of paralysis decreased, but the
decreases observed from year to year were not at the level of
statistical significance (p>0.05) (Table 3). Decreases were
also observed in both transient and permanent injury in the
years 2011–2014, as well as between successive pairs of years
after exposure to IONM, but these decreases were not statis-
tically significant (p>0.05). A steady downward trend in the
incidence of both transient and permanent injury was clearly
visible in the period 2011–2014. Bilateral paresis occurred in
two patients (1.68 %) in 2011 before the introduction of
IONM, in one patient (1.07 %) in 2012, and in one (0.92 %)
in 2013; all of these were cases of transient paresis.
Over the 4 years, after three exposures to IONM, the type
of thyroid surgery procedures performed without IONM
changed. The number of total thyroidectomies rose, while
the number of partial procedures declined (p<0.0001). The
biggest change took place between 2011 and 2012, after the
first 101 thyroid operations performed with IONM
(p<0.0001). The same trend continued following the second
3-month period working with IONM (p=0.0019). No statis-
tically significant change was observed in the type of proce-
dure between 2013 and 2014, after the third exposure to
IONM (p > 0.05); in 2014, partial procedures had been
completely replaced by radical operations (Table 4).
The mean operative time for thyroidectomies using visual
RLN identification decreased following the introduction of
IONM and subsequen t pe r iods o f exposu re to
neuromonitoring; it was 121 min (±20.6) in 2012, 108 min
(±34.08) in 2013, and 94 min (±28.56) in 2014 (p<0.001).
Discussion
In 1938, Lahey stated that careful dissection of the RLN does
not increase the rate of RLN injury during thyroid surgery but
definitely reduces the frequency of such injuries; that was the
beginning of a new era in thyroid surgery [12]. The need for
RLN identification was also confirmed by a 1994 multicenter
study by Jatzko et al., which, on the basis of 12,211 thyroid
operations, demonstrated that in patients without visual RLN
identification, the rate of transient and permanent paralysis
was 7.9 and 5.2 %, respectively; this was significantly higher
than in the group with visualization of the nerve, where the
rates were, respectively, 2.7 and 1.2 %. [4]. Currently, RLN
identification is the gold standard in thyroid surgery [5, 6, 13];
we no longer wonder whether to identify the RLN during
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thyroid surgery, but how to learn to do it successfully. Up until
now, more experienced surgeons have taught colleagues how
to identify the RLN [14], or magnifying glasses have been
used to facilitate its identification. However, it is not always
easy; Sturnilo et al. pointed out that in approximately 18 % of
patients, localization of the nerve during thyroid surgery failed
on both sides; the failure rate climbed to as much as 42 % in
reoperations [15].
Given the difficulty of identifying the RLN, the introduc-
tion of intraoperative neuromonitoring in 1966 by Shedd [16]
seems to be the next breakthrough in thyroid surgery. A num-
ber of reports have been published indicating that with IONM,
RLN identification reaches 98–100 % [13, 17–20].
Furthermore, several publications have reported a reduction
in postoperative complications when utilizing IONM.
Barczyński et al. showed that when IONM was used, the
incidence of early paralysis was 2.9 % lower in high-risk
operations and 0.9 % lower in low-risk surgery compared to
the same procedures performed without IONM [13].
Therefore, the optimum would be to use IONM in all thyroid
surgery, but currently, only some facilities can afford it for
economic reasons [21–23]. In Poland, in 2011, the first con-
ference of the Polish Study Group for IONM of the Polish
Club of Endocrine Surgeons took place, and its members
agreed upon the need for selective use of neuromonitoring in
at least challenging thyroid operations and for education of
residents in training [24]. Since then, a gradual but steady
increase in the use of this technique has been observed in
Poland. Given the financial constraints limiting the wide-
spread use of IONM in thyroid surgery, it may be worth con-
sidering ensuring surgeons at least brief exposure to IONM.
The aim of this study was to evaluate the effects of working
with IONM as part of a surgeon’s training in the skill of RLN
identification, as well as evaluating the quality of surgical treat-
ment after the surgeons’ exposure to IONM. For this purpose,
the authors used IONM for 3-month periods for three consecu-
tive years, and the skills gained while working with IONMwere
then used in operations without IONM during the study period.
Although the surgeons participating in the study carry out
about 60 thyroid operations annually, they identified the RLN
in only 45.71 % of the cases in the period before the introduc-
tion of IONM. This resulted from the surgeons’ inexperience
in RLN identification due to the fairly high percentage of
partial thyroid procedures performed prior to the introduction
of neuromonitoring (52.1 %). In partial procedures, the nerve
was not routinely identified; while in complete resections, the
technique of carefully following the capsule of the thyroid
gland was used.
It turned out that after the first 3-month exposure to
IONM—i.e., after 101 procedures—the rate of visual RLN
identification rose from 45.71 to 86.66 % (p < 0.0001).
Further experience with IONM in 2013 and 2014 resulted in
additional increases in the identification rate, to 90.81 and
91.3 %, respectively, but these increases were not at the level
of statistical significance. Considering the whole 3-year period
of working with IONM, the increase in RLN identification
was statistically significant (p< 0.0001). This shows that
IONM is a good tool for learning RLN identification and that
it takes only 100 monitored procedures to achieve this goal.
But it should be noted that increase in the surgeons’ visual
RLN identification abilities was noted only in primary opera-
tions (p<0.0001) and not in reoperations (p=0.4268). This
fact can be interpreted in two ways. Perhaps, the number of
operations with IONMwas insufficient to learn accurate visu-
al identification in cases of recurrent goiter; on the other hand,
perhaps, reoperations require unconditional use of IONM due
to the varying position of the RLN in such cases. This aspect
requires further study.
The use of IONM—in particular mapping the RLN and the
possibility of electrophysiological confirmation that we have
found the RLN—undoubtedly contributed to the development
of the authors’ skills in visual RLN identification in operations
without neuromonitoring. Using IONM allowed us to learn
not only about the typical course of the nerve but also its
anatomical variants as positions relative to the inferior thyroid
artery or branching. Mapping the RLN and electrophysiolog-
ical confirmation was especially useful in reoperations, in
which the nerve could be dislocated or imbedded in a scar.
It is difficult to relate the results obtained in the present
study to other papers on a similar subject, because so far, most
of them have focused solely on assessing the IONM method
[13, 21], not on its educational value. However, an interesting
study by Duclos et al. is worth noting; in that study, it was
found that even surgeons with extensive experience in thyroid
surgery benefited from the change in their surgical technique
after exposure to IONM [25].
Identification of the RLN is reflected both in the rate of
injuries to it and the extent of the surgery performed, especial-
ly in benign multinodular goiter.
The authors of this study, prior to the introduction of
IONM, reported a fairly high percentage of early complica-
tions: 6.8 %, including 4.25 % transient and 2.55 % perma-
nent. The first 3-month exposure to IONM resulted in a con-
siderable decline in early RLN paralysis in subsequent opera-
tions without neuromonitoring (3.61 %), although the reduc-
tion in these complications was not statistically significant.
Interestingly, the downward trend in the incidence of RLN
paralysis in non-monitored procedures persisted after further
exposure to IONM in 2013 and 2014, when the rate of early
paralysis dropped to 2.65 and 1.45 %, respectively. However,
it was only after 3 years of IONM use that the observed de-
crease in the incidence of RLN injuries reached the level of
statistical significance (p=0.043). This shows that as RLN
identification skills increase, the rate of postoperative nerve
injury decreased. It needs to be noted, however, that while the
exposure to IONM fairly quickly resulted in a statistically
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significant increase in the surgeons’ ability to identify the
RLN—after only 101 operations—it took 3 years and more
than 200 thyroid procedures to attain a statistically significant
reduction in RLN paralysis.
The authors also assessed the change in the scope of the
surgical procedures performed with RLN visualization, but
after the experience of working with neuromonitoring. In re-
cent years, total thyroidectomy is increasingly reported as the
preferred treatment in nodular goiter [26, 27], but an inability
to identify the RLN can lead to a conscious choice of partial
resection procedures. This was the case for the authors of this
study. In 2011, before the introduction of IONM, more than
half of the operations carried out in the authors’ department
were bilateral subtotal thyroidectomy or Dunhill’s procedure.
After each subsequent year of working with IONM, and as the
surgeons’ ability to identify the RLN increased, the extent of
thyroid operations also increased. The change in the type of
procedures performed was the largest after the first 2 years of
experience with IONM, when total resections accounted for
86.02 % (2012) and 98.15 % (2013) of the procedures carried
out. These increases were statistically significant (p=0.0019).
The third exposure to IONM did not result in any further
significant change in the types of procedure; partial removal
of the thyroid gland was by then almost completely eliminat-
ed. The greater extent of the thyroid resections was not asso-
ciated with higher rates of RLN injuries.
The results obtained in the present study are very similar to
those presented by Dralle et al. in an article form 2014, which
is a summary of the results of thyroid surgery in Germany
between 2005 and 2011 [28]. This large multicenter study
showed that over the years, the percentage of total resection
procedures in relation to partial resections rose to 59% in men
and 64 % in women. Also, it was found that with increase in
the number of total resections, there was a decrease in post-
operative RLN injury, from 1.06 to 0.86 %. It is worth noting
that in Germany, most thyroid procedures have been per-
formed with IONM for over 10 years. That multicenter study
indicates the directions thyroid surgery takes after the intro-
duction IONM, and the data from the present study confirm
that trend: greater extent of surgery with fewer complications.
A study by Alesina et al. about the educational value of
IONM is worth mentioning. In that paper, the RLN injury rate
during thyroid surgery performed by an inexperienced sur-
geons without experienced oversight using IONM was
2.7 %, and the results were no worse than those obtained
during surgery performed by a an inexperienced surgeons
assisted by an experienced surgeon: 2.6 % [29]. Of course,
that work does not indicate that IONM can replace experi-
enced assistance during thyroid surgery, but it certainly illus-
trates the great value of IONM in the process of learning to
identify and preserve the RLN.
The results of this study indicate how important even brief
exposure to IONM can be. It appears that the greatest advances
in RLN identification and the ability to completely remove the
thyroid occur after the first, relatively short exposure to
IONM—after only about 100 procedures. Statistically signifi-
cant reductions in the prevalence of RLN injuries come later; it
takes more than 200 operations with IONM to achieve that.
Finally, it is worth mentioning that the authors are aware
that this study has some limitations. Both the very low rate of
visual RLN identification at our center before 2012 and the
training in Krakow could have influenced the final results.
The very low rate of visual RLN identification at our center
before 2012 was due to the large number of subtotal thyroid
operations, where the recurrent laryngeal nerve was not iden-
tified in most cases. It is the reason why the surgeons have a
small experience in visual RLN identification. An additional
limitation of this type of study is that the rate of visual iden-
tification of the RLN is purely subjective, based solely on the
surgeon saying that they saw the nerve in typical localisation
using standard approaches to the nerve and typical landmarks
to find the nerve. That is a major potential confounding factor
in the study.
Despite these limitations, the results show the crucial influ-
ence of neuromonitoring on the surgeons’ skills and on the
change in surgical thyroid strategy.
In addition, it would be valuable to compare the results
among patients operated with and without IONM, but after
initial training with a focus on such aspects as the rate of RLN
identification, the number of complications, and the duration
of thyroid operations, but the issue is a separate ongoing study.
Conclusions
Three months of exposure to IONM each year from 2012 to
2014 allowed for an increase in RLN identification in totally
or near totally resected lobes of the thyroid (p<0.0001), a
decrease in the prevalence of RLN injury (p<0.05), and an
increase in the safe utilization of total thyroidectomy
(p < 0.0001) in non-monitored thyroid operations. Thus,
IONM is a valuable tool for surgical training.
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